Multisensory Rehabilitation for Hemianopia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help individuals with hemianopia (partial vision loss in half of the visual field) improve their vision. The treatment, called the Multisensory Rehabilitation Paradigm, involves a special training program that uses both sight and sound to retrain the brain. Participants attend weekly sessions with coordinated visual and auditory stimulation. The trial seeks individuals with stable hemianopia for more than six months, no hearing or cognitive issues, and a willingness to join a three-month program.
As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research and potentially enhance vision through innovative therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this multisensory rehabilitation paradigm is safe for hemianopia?
Research has shown that multisensory rehabilitation is safe for people with hemianopia, a condition where half of the field of vision is lost. Past studies reported no safety issues with this therapy. This treatment combines sight and sound to help improve vision and has been found to quickly and effectively restore visual function. Participants have handled the therapy well, making it a promising option for those seeking to regain vision.12345
Why are researchers excited about this trial?
Researchers are excited about the multisensory rehabilitation paradigm for hemianopia because it leverages a novel method of combining visual and auditory stimuli to potentially enhance vision recovery. Unlike traditional treatments that often focus solely on visual exercises or compensatory strategies, this approach integrates high-density, spatiotemporally congruent sensory inputs, which may promote more holistic and effective neural adaptation. By engaging multiple senses simultaneously, this method could offer a more dynamic and interactive way to retrain the brain, providing hope for improved functional recovery in those with unilateral blindness.
What evidence suggests that this multisensory rehabilitation paradigm is effective for hemianopia?
Research has shown that multisensory therapy, which combines sight and sound, can quickly and effectively improve vision in people with hemianopia. Hemianopia occurs when a person loses vision on one side. In this trial, unilaterally blind participants will undergo visual-auditory stimulation as part of the multisensory rehabilitation paradigm. Studies indicate that this therapy helps people regain sight in their blind area. Engaging the brain with both visual and auditory stimulation appears to enhance recovery. Overall, evidence suggests that this therapy offers a promising way to restore vision in those affected by hemianopia.12367
Who Is on the Research Team?
Benjamin A Rowland, PhD
Principal Investigator
Wake Forest Health Sciences
Are You a Good Fit for This Trial?
This trial is for adults under 85 years old with a stable condition called hemianopia, where half of the visual field is lost. Participants should not have attention deficits related to vision (hemineglect) and must be able to see well enough in their unaffected field to do certain visual tasks.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in weekly multisensory training sessions with visual-auditory stimulation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Multisensory Rehabilitation Paradigm
Multisensory Rehabilitation Paradigm is already approved in United States for the following indications:
- Hemianopia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Neuroscience Clinical Trial and Innovation Center (NCTIC)
Collaborator